MK7418

· NovaCardia, Inc. (a subsidiary of Merck & Co.)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK7418, covering 2008-04-04 to 2008-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Effects of MK7418 on Diuresis and Renal Function in Congestive Heart Failure Patients [Phase 2]